DarioHealth (DRIO) Competitors

DarioHealth (NASDAQ:DRIO) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.

Is DRIO or XAIR more profitable?

DarioHealth has a net margin of -205.62% compared to Beyond Air's net margin of -2,369.17%. DarioHealth's return on equity of -72.16% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DarioHealth	-205.62%	-72.16%	-40.74%
Beyond Air	-2,369.17%	-227.29%	-106.51%

Does the media refer more to DRIO or XAIR?

In the previous week, Beyond Air had 5 more articles in the media than DarioHealth. MarketBeat recorded 5 mentions for Beyond Air and 0 mentions for DarioHealth. Beyond Air's average media sentiment score of 0.55 beat DarioHealth's score of 0.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Overall Sentiment
DarioHealth	Neutral
Beyond Air	Positive

Do analysts prefer DRIO or XAIR?

DarioHealth presently has a consensus target price of $4.00, indicating a potential upside of 412.82%. Beyond Air has a consensus target price of $3.67, indicating a potential upside of 645.86%. Given Beyond Air's higher possible upside, analysts clearly believe Beyond Air is more favorable than DarioHealth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Beyond Air	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

Which has more risk & volatility, DRIO or XAIR?

DarioHealth has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.18, meaning that its share price is 118% less volatile than the S&P 500.

Does the MarketBeat Community believe in DRIO or XAIR?

DarioHealth received 190 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 67.04% of users gave DarioHealth an outperform vote.

Company	Underperform	Outperform
DarioHealth	Outperform Votes 238 67.04%	Underperform Votes 117 32.96%
Beyond Air	Outperform Votes 48 69.57%	Underperform Votes 21 30.43%

Which has better valuation & earnings, DRIO or XAIR?

DarioHealth has higher revenue and earnings than Beyond Air. DarioHealth is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$20.35M	1.31	-$59.43M	-$0.94	-0.83
Beyond Air	$1.16M	30.59	-$60.24M	-$1.41	-0.35

Do insiders & institutionals have more ownership in DRIO or XAIR?

33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 16.5% of DarioHealth shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

DarioHealth and Beyond Air tied by winning 9 of the 18 factors compared between the two stocks.